The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year. Trials have shown that the R21/Matrix vaccine, developed by Oxford University together with the Serum Institute of India, reduces malaria by up to 75%. It can be manufactured cheaply and on a mass scale. The Conversation Weekly spoke to chief investigator Adrian Hill, who is also director of the Jenner Institute at the University of Oxford, about this revolutionary vaccine. Below are edited excerpts from the podcast.
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Conversation
Adrian Hill, Director of the Jenner Institute, University of Oxford
'We could eradicate malaria by 2040' says expert after revolutionary vaccine is approved by WHO
Vaccine
Malaria
Adrian Hill
the Serum Institute of India
Oxford University
the University of Oxford
The Conversation Weekly
World Health Organization
Africa
Podcast
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks